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Background
The IFNg ELISpot assay is used widely for high through-
put screening of HIV-specific responses in studies of HIV
infection and vaccine studies. However, dual production of
IFNg/IL-2 and increased proliferative capacity may be
associated with better natural control of HIV infection.
We evaluated a novel fluorospot assay enabling the identi-
fication of dual IFNg/IL-2 producing antigen-specific cells
and compared it with intracellular cytokine staining by
standard flow cytometry in individuals with natural con-
trol of HIV-infection.
Methods
PBMC from five untreated HIV-infected individuals were
stimulated overnight with HIV peptides or controls in
dual IFNg/IL-2 pre-coated plates. Peptide arrays were spe-
cifically selected based on the individual HLA type.
Secreted IFNg and IL-2 were detected using fluorescent-
conjugated antibodies. Fluorescent spots were enumerated
on the iSpot AID reader. Responses were considered posi-
tive if >50 spots/million cells SFU after background sub-
traction.Positive responses were then evaluated by flow
cytometry using the Gallios flow cytometer.
Results
Dual IL-2/IFNg producing cells were detected to anti-
CD3-stimulated PBMC from all patients. IFNg responses
alone were detected to 35 of 136 HLA-restricted peptides
tested (median =73, 52-4190 SFU) across the 5 patients
(1/19, 5/19, 7/28, 9/15 and 13/55 for each patient), while
IL-2 responses were either low grade or undetectable for
the majority of HIV peptides tested. Dual IFNg/IL-2 pro-
ducing HIV-specific T cells were not detected using the
fluorospot assay. 24/35 peptides induced CD8 T cell-IFNg
production by flow cytometry.
Conclusion
HIV-specific mono-IFNg responses were detected using
the novel fluorospot assay. However limited HIV-specific
dual IFNg/IL-2 responses were detected in this patient
group. A greater number of epitope-specific positive
responses were detected in the fluorospot compared with
flow cytometry suggesting the fluorospot may be more
sensitive in detecting a greater breadth of epitope-specific
T cell responses, and therefore better for screening pur-
poses than flow cytometric methods.
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